Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.

Watkins RR, Holubar M, David MZ.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01216-19. doi: 10.1128/AAC.01216-19. [Epub ahead of print] Review.

PMID:
31527033
2.

Long-Term Intrahost Evolution of Methicillin Resistant Staphylococcus aureus Among Cystic Fibrosis Patients With Respiratory Carriage.

Azarian T, Ridgway JP, Yin Z, David MZ.

Front Genet. 2019 Jun 12;10:546. doi: 10.3389/fgene.2019.00546. eCollection 2019.

3.

Effects of Including Variables Such as Length of Stay in a Propensity Score Analysis With Costs as Outcome.

Hemmige V, David MZ.

Clin Infect Dis. 2019 Nov 13;69(11):2039-2040. doi: 10.1093/cid/ciz347. No abstract available.

PMID:
31044231
4.

A New Indication for Pneumococcal Vaccination?

David MZ.

Am J Kidney Dis. 2019 Jul;74(1):9-11. doi: 10.1053/j.ajkd.2019.03.420. Epub 2019 Apr 27. No abstract available.

PMID:
31040090
5.

The Importance of Staphylococcus aureus Genotypes in Outcomes and Complications of Bacteremia.

David MZ.

Clin Infect Dis. 2019 Nov 13;69(11):1878-1880. doi: 10.1093/cid/ciz114. No abstract available.

PMID:
31001630
6.

Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With S. aureus Skin and Soft Tissue Infections From Controls.

Rigat F, Bartolini E, Dalsass M, Kumar N, Marchi S, Speziale P, Maione D, Chen L, Romano MR, Alegre ML, Bagnoli F, Daum RS, David MZ.

Front Immunol. 2019 Feb 7;10:114. doi: 10.3389/fimmu.2019.00114. eCollection 2019.

7.

USA300 Staphylococcus aureus persists on multiple body sites following an infection.

Read TD, Petit RA 3rd, Yin Z, Montgomery T, McNulty MC, David MZ.

BMC Microbiol. 2018 Dec 5;18(1):206. doi: 10.1186/s12866-018-1336-z.

8.

An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC).

Saeed K, Bal AM, Gould IM, David MZ, Dryden M, Giannitsioti E, Hijazi K, Meisner JA, Esposito S, Scaglione F, Tattevin P, Voss A.

Int J Antimicrob Agents. 2019 Jan;53(1):9-15. doi: 10.1016/j.ijantimicag.2018.09.014. Epub 2018 Sep 19. No abstract available.

PMID:
30240836
9.

Decreasing Incidence of Skin and Soft-tissue Infections in 86 US Emergency Departments, 2009-2014.

Morgan E, Hohmann S, Ridgway JP, Daum RS, David MZ.

Clin Infect Dis. 2019 Jan 18;68(3):453-459. doi: 10.1093/cid/ciy509.

PMID:
29912305
10.

Hospital Volume of Immunosuppressed Patients with Sepsis and Sepsis Mortality.

Greenberg JA, Hohmann SF, James BD, Shah RC, Hall JB, Kress JP, David MZ.

Ann Am Thorac Soc. 2018 Aug;15(8):962-969. doi: 10.1513/AnnalsATS.201710-819OC.

11.

Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality.

Greenberg JA, Hrusch CL, Jaffery MR, David MZ, Daum RS, Hall JB, Kress JP, Sperling AI, Verhoef PA.

Crit Care. 2018 Apr 25;22(1):107. doi: 10.1186/s13054-018-2025-x.

12.

Corrigendum to 'Panton-Valentine Leucocidin (PVL) Staphylococcus aureus a position statement from the International Society of Chemotherapy' [International Journal of Antimicrobial Agents 51/1 (2018) 16-25].

Saeed K, Gould I, Esposito S, Ahmad-Saeed N, Ahmed SS, Alp E, Bal AM, Bassetti M, Bonnet E, Chan M, Coombs G, Dancer SJ, David MZ, De Simone G, Dryden M, Guardabassi L, Hanitsch LG, Hijazi K, Kruger R, Lee A, Leistner R, Pagliano P, Righi E, Schneider-Burrus S, Skov RL, Tattevin P, VanWamel W, Vos MC, Voss A; International Society of Chemotherapy.

Int J Antimicrob Agents. 2018 Jul;52(1):125. doi: 10.1016/j.ijantimicag.2018.03.005. Epub 2018 Mar 21. No abstract available.

PMID:
29571899
13.

In Vitro Susceptibility of Ciprofloxacin-Resistant Methicillin-Resistant Staphylococcus aureus to Ototopical Therapy.

Walker DD, David MZ, Catalano D, Daum R, Gluth MB.

Otolaryngol Head Neck Surg. 2018 May;158(5):923-929. doi: 10.1177/0194599818762382. Epub 2018 Mar 13.

PMID:
29529928
14.

Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy.

Saeed K, Gould I, Esposito S, Ahmad-Saeed N, Ahmed SS, Alp E, Bal AM, Bassetti M, Bonnet E, Chan M, Coombs G, Dancer SJ, David MZ, De Simone G, Dryden M, Guardabassi L, Hanitsch LG, Hijazi K, Kr├╝ger R, Lee A, Leistner R, Pagliano P, Righi E, Schneider-Burrus S, Skov RL, Tattevin P, Van Wamel W, Vos MC, Voss A; International Society of Chemotherapy.

Int J Antimicrob Agents. 2018 Jan;51(1):16-25. doi: 10.1016/j.ijantimicag.2017.11.002. Epub 2017 Nov 22. Review. No abstract available. Erratum in: Int J Antimicrob Agents. 2018 Mar 20;:.

PMID:
29174420
15.

S. aureus Infections in Chicago, 2006-2014: Increase in CA MSSA and Decrease in MRSA Incidence.

Acree ME, Morgan E, David MZ.

Infect Control Hosp Epidemiol. 2017 Oct;38(10):1226-1234. doi: 10.1017/ice.2017.177. Erratum in: Infect Control Hosp Epidemiol. 2018 Feb;39(2):251-252.

PMID:
28903801
16.

Treatment of Staphylococcus aureus Infections.

David MZ, Daum RS.

Curr Top Microbiol Immunol. 2017;409:325-383. doi: 10.1007/82_2017_42. Review.

PMID:
28900682
17.

Decreasing Incidence of Skin and Soft Tissue Infections With a Seasonal Pattern at an Academic Medical Center, 2006-2014.

Morgan E, Daum RS, David MZ.

Open Forum Infect Dis. 2016 Aug 30;3(4):ofw179. doi: 10.1093/ofid/ofw179. eCollection 2016 Oct.

18.

Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.

Bal AM, David MZ, Garau J, Gottlieb T, Mazzei T, Scaglione F, Tattevin P, Gould IM.

J Glob Antimicrob Resist. 2017 Sep;10:295-303. doi: 10.1016/j.jgar.2017.05.019. Epub 2017 Jul 18. Review.

PMID:
28732783
19.

Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.

David MZ, Dryden M, Gottlieb T, Tattevin P, Gould IM.

Int J Antimicrob Agents. 2017 Sep;50(3):303-307. doi: 10.1016/j.ijantimicag.2017.05.006. Epub 2017 Jun 27. Review.

20.

Diffusion of clindamycin-resistant and erythromycin-resistant methicillin-susceptible Staphylococcus aureus (MSSA), potential ST398, in United States Veterans Health Administration Hospitals, 2003-2014.

Carrel M, Goto M, Schweizer ML, David MZ, Livorsi D, Perencevich EN.

Antimicrob Resist Infect Control. 2017 Jun 5;6:55. doi: 10.1186/s13756-017-0212-1. eCollection 2017.

21.

MRSA community pneumonia: a global perspective on resistance.

David MZ.

Lancet Infect Dis. 2016 Dec;16(12):1309-1310. doi: 10.1016/S1473-3099(16)30312-7. Epub 2016 Sep 1. No abstract available.

PMID:
27593582
22.

Sequential Organ Failure Assessment Score Modified for Recent Infection in Patients With Hematologic Malignant Tumors and Severe Sepsis.

Greenberg JA, David MZ, Churpek MM, Pitrak DL, Hall JB, Kress JP.

Am J Crit Care. 2016 Sep;25(5):409-17. doi: 10.4037/ajcc2016281.

23.

Identification of source and sink populations for the emergence and global spread of the East-Asia clone of community-associated MRSA.

Ward MJ, Goncheva M, Richardson E, McAdam PR, Raftis E, Kearns A, Daum RS, David MZ, Lauderdale TL, Edwards GF, Nimmo GR, Coombs GW, Huijsdens X, Woolhouse ME, Fitzgerald JR.

Genome Biol. 2016 Jul 26;17(1):160. doi: 10.1186/s13059-016-1022-0.

24.

Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans.

Alegre ML, Chen L, David MZ, Bartman C, Boyle-Vavra S, Kumar N, Chong AS, Daum RS.

J Immunol. 2016 Aug 15;197(4):1118-26. doi: 10.4049/jimmunol.1600549. Epub 2016 Jul 11.

25.

Intrahost Evolution of Methicillin-Resistant Staphylococcus aureus USA300 Among Individuals With Reoccurring Skin and Soft-Tissue Infections.

Azarian T, Daum RS, Petty LA, Steinbeck JL, Yin Z, Nolan D, Boyle-Vavra S, Hanage WP, Salemi M, David MZ.

J Infect Dis. 2016 Sep 15;214(6):895-905. doi: 10.1093/infdis/jiw242. Epub 2016 Jun 10.

26.
27.

Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14.

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J 4th, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ.

J Clin Virol. 2016 Jul;80:12-9. doi: 10.1016/j.jcv.2016.04.008. Epub 2016 Apr 14.

PMID:
27130980
28.

Fulminant hepatic failure attributed to infection with human herpesvirus 6 (HHV-6) in an immunocompetent woman: A case report and review of the literature.

Charnot-Katsikas A, Baewer D, Cook L, David MZ.

J Clin Virol. 2016 Feb;75:27-32. doi: 10.1016/j.jcv.2015.12.002. Epub 2015 Dec 14.

PMID:
26745830
29.

Validation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases.

Greenberg JA, Hohmann SF, Hall JB, Kress JP, David MZ.

Ann Am Thorac Soc. 2016 Feb;13(2):253-8. doi: 10.1513/AnnalsATS.201507-415BC.

30.

Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study.

Hemmige V, McNulty M, Silverman E, David MZ.

BMC Infect Dis. 2015 Oct 26;15:455. doi: 10.1186/s12879-015-1216-1.

31.

Do citation trends reflect epidemiologic patterns? Assessing MRSA, emerging and re-emerging pathogens, 1963-2014.

Morgan E, David MZ.

BMC Infect Dis. 2015 Oct 26;15:460. doi: 10.1186/s12879-015-1182-7.

32.

USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000-2013.

Carrel M, Perencevich EN, David MZ.

Emerg Infect Dis. 2015 Nov;21(11):1973-80. doi: 10.3201/eid2111.150452.

33.

Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients.

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ.

Infect Control Hosp Epidemiol. 2015 Nov;36(11):1251-60. doi: 10.1017/ice.2015.170. Epub 2015 Jul 30.

PMID:
26224364
34.

Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997.

David MZ, Acree ME, Sieth JJ, Boxrud DJ, Dobbins G, Lynfield R, Boyle-Vavra S, Daum RS.

J Clin Microbiol. 2015 Aug;53(8):2486-91. doi: 10.1128/JCM.00096-15. Epub 2015 May 27.

35.

Host factors that contribute to recurrent staphylococcal skin infection.

Montgomery CP, David MZ, Daum RS.

Curr Opin Infect Dis. 2015 Jun;28(3):253-8. doi: 10.1097/QCO.0000000000000156. Review.

36.

USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus.

Boyle-Vavra S, Li X, Alam MT, Read TD, Sieth J, Cywes-Bentley C, Dobbins G, David MZ, Kumar N, Eells SJ, Miller LG, Boxrud DJ, Chambers HF, Lynfield R, Lee JC, Daum RS.

MBio. 2015 Apr 7;6(2). pii: e02585-14. doi: 10.1128/mBio.02585-14.

37.

Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing.

Alam MT, Read TD, Petit RA 3rd, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ.

MBio. 2015 Mar 10;6(2):e00054. doi: 10.1128/mBio.00054-15.

38.

High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department.

Kumar N, David MZ, Boyle-Vavra S, Sieth J, Daum RS.

J Clin Microbiol. 2015 Mar;53(3):810-5. doi: 10.1128/JCM.03221-14. Epub 2014 Dec 24.

39.

M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.

Zhao L, David MZ, Hyjek E, Chang A, Meehan SM.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):54-62. doi: 10.2215/CJN.03230314. Epub 2014 Dec 16.

40.

Preventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals.

Larsen J, David MZ, Vos MC, Coombs GW, Grundmann H, Harbarth S, Voss A, Skov RL.

J Glob Antimicrob Resist. 2014 Dec;2(4):260-268. doi: 10.1016/j.jgar.2014.09.003. Epub 2014 Oct 2. Review.

PMID:
27873685
41.

Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors.

Miller LG, Eells SJ, David MZ, Ortiz N, Taylor AR, Kumar N, Cruz D, Boyle-Vavra S, Daum RS.

Clin Infect Dis. 2015 Mar 1;60(5):753-63. doi: 10.1093/cid/ciu943. Epub 2014 Nov 26.

42.

A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail.

David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Porsa E, Schumm LP, Boyle-Vavra S, Daum RS.

Infect Control Hosp Epidemiol. 2014 Dec;35(12):1466-73. doi: 10.1086/678606.

PMID:
25419768
43.

Persistent environmental contamination with USA300 methicillin-resistant Staphylococcus aureus and other pathogenic strain types in households with S. aureus skin infections.

Eells SJ, David MZ, Taylor A, Ortiz N, Kumar N, Sieth J, Boyle-Vavra S, Daum RS, Miller LG.

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1373-82. doi: 10.1086/678414. Epub 2014 Sep 22.

PMID:
25333432
44.

Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era.

Hemmige V, McNulty M, Silverman E, David MZ.

Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):339-47. doi: 10.1007/s10096-014-2237-1. Epub 2014 Sep 12.

PMID:
25213720
45.

A national survey of skin infections, care behaviors and MRSA knowledge in the United States.

Wilder JR, Wegener DT, David MZ, Macal C, Daum R, Lauderdale DS.

PLoS One. 2014 Aug 19;9(8):e104277. doi: 10.1371/journal.pone.0104277. eCollection 2014.

46.

Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detainees.

David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Taylor AR, Zychowski DL, Porsa E, Boyle-Vavra S, Daum RS.

J Clin Microbiol. 2014 Sep;52(9):3422-5. doi: 10.1128/JCM.01190-14. Epub 2014 Jun 23.

47.

Modeling the transmission of community-associated methicillin-resistant Staphylococcus aureus: a dynamic agent-based simulation.

Macal CM, North MJ, Collier N, Dukic VM, Wegener DT, David MZ, Daum RS, Schumm P, Evans JA, Wilder JR, Miller LG, Eells SJ, Lauderdale DS.

J Transl Med. 2014 May 12;12:124. doi: 10.1186/1479-5876-12-124.

48.

Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections.

David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG Jr, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth JJ, Volinski J, Spellberg B.

Clin Infect Dis. 2014 Sep 15;59(6):798-807. doi: 10.1093/cid/ciu410. Epub 2014 May 30.

49.

Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies.

Greenberg JA, David MZ, Pitrak DL, Hall JB, Kress JP.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1615-21. doi: 10.1007/s10096-014-2114-y. Epub 2014 May 3.

PMID:
24791952
50.

Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008.

David MZ, Cadilla A, Boyle-Vavra S, Daum RS.

PLoS One. 2014 Apr 22;9(4):e92760. doi: 10.1371/journal.pone.0092760. eCollection 2014.

Supplemental Content

Loading ...
Support Center